| J |
| Jacobs F. |
- |
Development of a real-time NASBA for herpes simples virus 1+2 |
| Jacobs M. |
- |
Antibiotic resistance, serotypes, and clonal composition of Streptococcus pneumoniae in clinical trials of acute otitis media pre- and post-launch of the 7 valent pneumococcal conjugate vaccine |
| Jacobs F. |
- |
Invasive nocardiosis: emergence of new species and usefulness of susceptibility testing |
| Jacobs M. |
- |
Automated nucleic acid extraction using the NucliSens easyMAG system for the recovery of DNA from various clinical specimen types |
| Jacobs E. |
- |
Prospective, multicentre in vitro study to determine resistance rates and comparative activity of moxifloxacin vs. clinical bacterial isolates from patients with respiratory tract infections (MOXIAKTIV study) |
| Jacobs F. |
- |
Development of a real-time NASBA respiratory syncytial virus assay |
| Jacobsen T. |
- |
Rising MRSA occurrence in Central Norway importance of swab sites |
| Jacobson M. |
- |
In vitro and in vivo release of daptomycin or vancomycin from polymethacrylate beads |
| Jacofsky D.J. |
- |
In vitro and in vivo release of daptomycin or vancomycin from polymethacrylate beads |
| |
- |
Kinetics of linezolid release from polymethylmethacrylate beads |
| Jacomo V. |
- |
Epidemiology and clinical features of bacteraemia in a tertiary care hospital over a twelve-year study period |
| Jacqueline C. |
- |
There is no correlation between the minimal inhibitory concentration of teicoplanin against Staphylococcus epidermidis and efficacy in the mouse sepsis/peritonitis model |
| Jafari R. |
- |
Study of human infection of cutaneous leishmaniasis in a focus of the disease, southern Iran |
| Jahn H. |
- |
A shift to Gram-negative bacteria in the intestinal microflora contributes to immunopathology of acute ileitis in the Toxoplasma gondii-driven mouse model of small intestinal inflammation |
| Jaimchariyatam N. |
- |
Diagnosis of dengue infection by enzyme-linked immunosorbent assay and reverse transcription-nested polymerase chain reaction from dried urine spots on filter paper |
| |
- |
Diagnosis of dengue infection by reverse transcription-nested polymerase chain reaction and enzyme linked immunosorbent assay using whole blood stored on filter paper |
| Jaka A. |
- |
Colonisation and antimicrobial resistance in tracheal aspirates of hospitalised patients in intensive care units of a tertiary medical care centre in Kosova |
| Jakab F. |
- |
Clinical characteristics of rotavirus, enteric adenovirus and astrovirus infections among hospitalised children in Hungary |
| Jakielaszek C. |
- |
Bacteriological outcomes with pharmacokinetically enhanced amoxicillin/clavulanate (2000/125 mg) in patients with community-acquired respiratory infection caused by Streptococcus pneumoniae, including drug-resistant strains |
| Jakimiak B. |
- |
Assessing susceptibility of fungi isolated from hospital environment to disinfectants |
| |
- |
Comparison assessment of antibacterial efficiency of finishes used in medical areas |
| Jakobsen L. |
- |
High prevalence of aac(3)-II encoding gentamicin resistance in Escherichia coli obtained from patients with urinary tract infections in a Danish hospital |
| |
- |
Distinctive ketolide interaction and resistance mechanisms |
| Jakupi X. |
- |
Colonisation and antimicrobial resistance in tracheal aspirates of hospitalised patients in intensive care units of a tertiary medical care centre in Kosova |
| Jalal S. |
- |
Expression of mRNA for efflux pump proteins in Pseudomonas aeruginosa strains from cystic fibrosis patients in relation to antibiotic resistance |
| Jalali N. |
- |
Seroepidemiology of Crimean-Congo haemorrhagic fever in local and imported sheep in Isfahan province, Iran in 2002 |
| Jalava J. |
- |
Prevalence of multiresistance among Streptococcus pneumoniae strains in Finland |
| |
- |
ESPAR: variation of antibiotic resistance in Enterococcus spp. isolates |
| Jalava and J. |
- |
Molecular genetics of extended-spectrum beta-lactamase among Escherichia coli and Klebsiella spp. isolates in Finland |
| Jamali A. |
- |
Acute morphine treatment reduce innate immunity against systematic infection of HSV-1 in mice |
| |
- |
DNA vaccination fails to induce protective immunity against herpes simplex virus type 1 in chronic morphine treatment mice |
| Jamalidoust M. |
- |
Development of type specific based glycoprotein G assay to identify of HSV-2 infection |
| |
- |
Evaluation of herpes simplex virus-1 latency in trigeminal ganglia of ocular and systemic infected mice |
| Jamdar S. |
- |
Spread of a carbapenem-resistant Pseudomonas aeruginosa associated with contamination of hand-washing facilities on an intensive care unit |
| James V.L.A. |
- |
International external quality assessment for C. trachomatis using EIA and molecular methods |
| James J. |
- |
Effectiveness and durability of tenofovir and didanosine as backbones in anti-retroviral naive patients |
| Jamshidi M. |
- |
Evaluation of awareness of healthcare workers about standard health precaution and isolation |
| Jamshidi A. |
- |
Evaluation of awareness of healthcare workers about standard health precaution and isolation |
| Jamshidi M. |
- |
Correlation between zinc level of serum and recurrent vulvovaginal candidiasis |
| Jan I. |
- |
Assessment of the MagNa pure compact system for extraction of Neisseria meningitidis and Streptococcus pneumoniae DNA from clinical CSF and blood specimens |
| Jang D. |
- |
Comparison of inhibition rates for vaginal and cervical swabs and urine for the diagnosis of Chlamydiatrachomatis by Aptima Combo 2, ProbeTec ET and Amplicor |
| Jang S.-J. |
- |
Pseudobacteraemia due to contaminated normal saline sponges |
| Janknegt R. |
- |
An additional measure for quantifying antibiotic use in hospitals |
| Janmohammadi N. |
- |
Efficacy of cotrimoxasol plus rifampin for six and eight weeks of therapy in childhood brucellosis |
| Janosi G. |
- |
Evaluation of antibiotic consumption and resistance patterns in a tertiary care surgical ICU and a medical ICU |
| Jansen R. |
- |
Giardia lamblia: different genotypes, different symptoms? |
| Janssens M. |
- |
Comparative in vitro activity of several antimicrobial agents against different Nocardia species |
| Janus C. |
- |
Telithromycin versus other first-line single-agent antibiotics in the treatment of community-acquired pneumonia: a randomised superiority trial |
| Jarlier V. |
- |
Clinical investigation of the new QNR-based mechanism of quinolone resistance in French teaching hospitals: dissemination among enterobacterial species and strains producing expanded spectrum beta-lactamase |
| Jarløv J.O. |
- |
Detection of high-level gentamicin resistance and genes encoding gentamicin resistance in invasive enterococci in Denmark |
| |
- |
Combined resistance to penicillin and gentamicin in community-acquired bacteraemia in Copenhagen County, 19912000 |
| Jaruratanasirikul S. |
- |
2 hour versus 0.5 hour infusion of imipenem in healthy volunteers |
| Jarza-Davila N. |
- |
Metallo-beta-lactamase production and susceptibility to antibiotics of Pseudomonas aeruginosa isolates from Zagreb, Croatia |
| |
- |
In vitro effect of subMICs of antibiotics on the antigenic structure of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis |
| |
- |
Confirmation of C. dubliniensis from other Candida spp. |
| Jasir A. |
- |
Molecular and clinical characteristics of invasive Group A streptococcal infections in Sweden |
| |
- |
First pan-European epidemiological and microbiological surveillance programme for severe S. pyogenes disease |
| |
- |
Severe group A streptococcal infections in Romania. A surveillance within the Strep-EURO project |
| Jdanuk A. |
- |
Prevalence of nosocomial pneumonia in severe trauma patients (according to autopsy data) |
| Jeansson S. |
- |
A new flexible automated sample preparation method based on paramagnetic particles for the isolation of Chlamydiatrachomatis from urine samples, for downstream analysis using three different naat systems |
| |
- |
The utility of cytomegalovirus (CMV) quantitative polymerase chain reaction in diagnosis of CMV disease in patients with AIDS |
| Jebelean C. |
- |
Antimicrobial susceptibility of invasive isolates of Enterobacteriaceae collected in Austria |
| Jefferies J.M.C. |
- |
Non-haemolytic isolates of serotype 1 pneumococci |
| Jefferson R. |
- |
Effectiveness and durability of tenofovir and didanosine as backbones in anti-retroviral naive patients |
| Jeffery A. |
- |
Antibiotic use and resistance in Gram-negative hospital pathogens |
| Jehl F. |
- |
Determination of FR900098, a promising antimalarial agent, in human serum by capillary electrophoresis for pharmacokinetic studies |
| Jelastopulu E. |
- |
Helicobacter pylori and association with histological findings in endoscopic biopsies in western Greece |
| Jenkins S.G. |
- |
Changes in the global distribution of Streptococcus pneumoniae serotypes from paediatric isolates collected in PROTEKT Year 1 (Y1; 19992000) compared to Year 4 (Y4; 20022003) |
| Jensen T.H. |
- |
Findings of Candida species in critically ill patients in context with pharmacokinetic-pharmacodynamic properties of antifungal therapy |
| Jensen T.G. |
- |
Detection of high-level gentamicin resistance and genes encoding gentamicin resistance in invasive enterococci in Denmark |
| Jensen A. |
- |
Invasive listeriosis in Denmark |
| Jensen C. |
- |
Invasive listeriosis in Denmark |
| Jensen D. |
- |
PK/PD of beta-lactam antibiotics in experimental urinary tract infection |
| Jensen I.M. |
- |
Semi-national surveillance of fungaemia in Denmark: species distribution and anti-fungal susceptibility |
| Jensen J.-K. |
- |
Chlamydophila psittaci in fulmars on the Faroe islands a disease risk to humans? |
| Jensen F.-H. |
- |
Disinfection of ambulances, using dry mist of hydrogen peroxide |
| Jensen K. |
- |
Production of penicillin in Denmark during World War II. An early warning against development of antibiotic resistance |
| Jensen P.Ø. |
- |
Garlic blocks the Pseudomonas aeruginosa communication systems and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections |
| Jensen J. |
- |
Procalcitonin trend identifies critically ill patients at high risk of mortality |
| Jeong S.H. |
- |
Prevalence of Ambler class A extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Korean hospitals |
| Jeong J.W. |
- |
Does vancomycin resistance emerge during the treatment of methicillin-resistant Staphylococcus aureus in respiratory tracts? |
| Jernberg C. |
- |
Long-term effects of antibiotic administration on clonal stability and emergence and persistence of resistance genes in the intestinal microflora |
| Jestus S. |
- |
Rapid drug sensitivity testing for M. tuberculosis using slide culture |
| Jesus de la Calle I. |
- |
Reverse hybridisation as tool for the identification of mycobacteria other than tuberculosis from clinical respiratory samples |
| |
- |
Comparison of a LightCycler real-time PCR method and the BDProbeTec ET system for direct detection of Mycobacterium tuberculosis complex in respiratory specimens |
| Jette L. |
- |
The International Circumpolar Surveillance System for population-based surveillance of invasive pneumococcal disease 19992003 |
| Jäger S. |
- |
Regulation of biofilm formation by SigmaB is a common mechanism in Staphylococcus epidermidis and is not mediated by the SigmaB dependent sarA transcript |
| |
- |
barAB a new regulatory gene locus mediating NaCl induction of Staphylococcus epidermidis biofilm formation |
| Jägerroos H. |
- |
Molecular epidemiology of an outbreak caused by methicillin-resistant Staphylococcus aureus in a health care ward and associated nursing home |
| Jõgi R. |
- |
Oral Ipsat P1A is a novel product to prevent antimicrobial resistance and antibiotic induced disturbance in gastrointestinal tract in humans |
| Jiang J. |
- |
Evaluation of a new kinetic amplification based assay for quantification of hepatitis C virus (HCV) RNA |
| Jianu C. |
- |
The prognostic value of cerebrospinal fluid procalcitonin in acute bacterial meningitis in children |
| |
- |
Outcome of invasive pulmonary aspergillosis under highly active antiretroviral therapy in a HIV-infected patient without appropriate antifungal drugs |
| |
- |
Meningo-encephalo-mielo-polyradiculonevritis with Mycobacterium tuberculosis: case report |
| Jimenez S. |
- |
DNA microarray format for detection of human papillomavirus: discrepancies between techniques applied to detect HPV DNA |
| Jimenez Pajares M.S. |
- |
Molecular characterisation of isoniazid and/or rifampicin-resistant Mycobacterium tuberculosis clinical strains isolated in Spain |
| Jiménez M.T. |
- |
Ten-year experience in bloodstream infections in liver transplant recipients. Changes in microbiological patterns between 19911995 and 19962000 |
| Jiménez R. |
- |
Listeria monocytogenes infection. A clinical and epidemiological report from a Spanish general community-based hospital |
| Jiménez S. |
- |
Second-line antituberculous drugs: usefulness of the E-test for susceptibility testing of multidrug-resistant Mycobacterium tuberculosis |
| Jiménez de Anta M.T. |
- |
Biofilm formation in uropathogenic Escherichia coli clinical isolates |
| |
- |
Trends in antimicrobial susceptibilities of viridans group streptococci isolated in patients with infective endocarditis from 1990 to 2003 |
| Jiménez-Barros M. |
- |
Effect of dehydroepiandrosterone in an experimental pneumonia model caused by Klebsiella pneumoniae |
| Jiménez-Mejías M.E. |
- |
Efficacy of imipenem, sulbactam and rifampin in an experimental meningitis model caused by multiresistant Acinetobacter baumannii |
| |
- |
Efficacy of rifampin, imipenem, and sulbactam in monotherapy and combination, in the experimental pneumonia caused by panresistant Acinetobacter baumannii |
| Joch J. |
- |
Computerised surveillance of nosocomial infections at a university hospital |
| Johansson A. |
- |
Typing of Staphylococcus epidermidis using multiple-locus variable-number tandem repeat analysis |
| Johnsen S.P. |
- |
Association of statin therapy with 30- and 180-day mortality in patients with bacteraemia: population-based cohort study |
| Johnson A.P. |
- |
Effect of erythromycin on the selection of linezolid resistance in hypermutable and clinical isolates of Staphylococcus aureus |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) in vitro antibacterial activity against selected species of Enterobacteriaceae in the United States |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) in vitro antibacterial activity against selected species of Enterobacteriaceae in the United States |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) In vitro antibacterial activity against Gram-positive and Gram-negative pathogens in Europe |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) In vitro antibacterial activity against Gram-positive and Gram-negative pathogens in Europe |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) United States in vitro antibacterial activity against selected species of Enterococcus spp. |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) United States in vitro antibacterial activity against selected species of Enterococcus spp. |
| Johnson B. |
- |
European in vitro antibacterial activity of tigecycline against methicillin-resistant and methicillin-sensitive Staphylococcus aureus isolates from the Tigecycline Evaluation Surveillance Trial (TEST) |
| Johnson J. |
- |
European in vitro antibacterial activity of tigecycline against methicillin-resistant and methicillin-sensitive Staphylococcus aureus isolates from the Tigecycline Evaluation Surveillance Trial (TEST) |
| Johnson A. |
- |
Susceptibility of pneumococci causing meningitis in England and Wales to recommended antimicrobials, 20012003 |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) In vitro antibacterial activity against Gram-positive and Gram-negative pathogens in Asia |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) In vitro antibacterial activity against Gram-positive and Gram-negative pathogens in Asia |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) European in vitro antibacterial activity against selected species of Enterobacteriaceae |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) European in vitro antibacterial activity against selected species of Enterobacteriaceae |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) Global in vitro antibacterial activity against Gram-positive and Gram-negative pathogens |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) Global in vitro antibacterial activity against Gram-positive and Gram-negative pathogens |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) Global in vitro antibacterial activity against selected species of Enterococcus spp. |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) Global in vitro antibacterial activity against selected species of Enterococcus spp. |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) Global in vitro antibacterial activity against selected species of glucose non-fermenting organisms |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) Global in vitro antibacterial activity against selected species of glucose non-fermenting organisms |
| Johnson K. |
- |
Evaluation of a new IgM test for detection of cytomegalovirus IgM antibody |
| Johnson B. |
- |
Addition of a biocatalytic oxygen-reducing agent may be required in the absence of fresh media (<12 hours old) when testing tigecycline using broth microdilution |
| Johnson J. |
- |
Addition of a biocatalytic oxygen-reducing agent may be required in the absence of fresh media (<12 hours old) when testing tigecycline using broth microdilution |
| Johnson B. |
- |
Global in vitro antibacterial activity of tigecycline against methicillin-resistant and methicillin-sensitive Staphylococcus aureus isolates from the Tigecycline Evaluation Surveillance Trial (TEST) |
| Johnson J. |
- |
Global in vitro antibacterial activity of tigecycline against methicillin-resistant and methicillin-sensitive Staphylococcus aureus isolates from the Tigecycline Evaluation Surveillance Trial (TEST) |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) European in vitro antibacterial activity against selected species of Enterococcus spp. |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) European in vitro antibacterial activity against selected species of Enterococcus spp. |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) European in vitro antibacterial activity against selected species of glucose non-fermenting organisms |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) European in vitro antibacterial activity against selected species of glucose non-fermenting organisms |
| Johnson A.P. |
- |
A comparison of trends in antibiotic resistance in Staphylococcus aureus and Streptococcus pneumoniae in the UK |
| Johnson J. |
- |
A comparative in vitro analysis of amoxicillin-clavulanic acid and seven comparative agents in 15,521 paediatric respiratory isolates |
| Johnson A.P. |
- |
In vitro selection of linezolid resistance in hypermutable and wild-type Staphylococcus aureus |
| |
- |
CTX-M-producing Escherichia coli now the dominant cephalosporin-resistant Enterobacteriaceae in London and SE England |
| Johnson E.M. |
- |
The importance of susceptibility testing |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) global in vitro antibacterial activity against selected species of Enterobacteriaceae |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) global in vitro antibacterial activity against selected species of Enterobacteriaceae |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) In vitro antibacterial activity against Gram-positive and Gram-negative pathogens in the United States |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) In vitro antibacterial activity against Gram-positive and Gram-negative pathogens in the United States |
| Johnson B. |
- |
United States in vitro antibacterial activity of tigecycline against methicillin-resistant and methicillin-sensitive Staphylococcus aureus isolates from the Tigecycline Evaluation Surveillance Trial (TEST) |
| Johnson J. |
- |
United States in vitro antibacterial activity of tigecycline against methicillin-resistant and methicillin-sensitive Staphylococcus aureus isolates from the Tigecycline Evaluation Surveillance Trial (TEST) |
| Johnson B. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) United States in vitro antibacterial activity against selected species of glucose non-fermenting organisms |
| Johnson J. |
- |
Tigecycline Evaluation Surveillance Trial (TEST) United States in vitro antibacterial activity against selected species of glucose non-fermenting organisms |
| Johnston J. |
- |
Evaluation of MicroScan Dried Overnight Panels compared to a NCCLS reference panel for daptomycin susceptibility testing with a challenge set of organisms |
| Johny M. |
- |
Extended spectrum b-lactamase producing Escherichia coli in a Kuwait hospital |
| Jomaa H. |
- |
Determination of FR900098, a promising antimalarial agent, in human serum by capillary electrophoresis for pharmacokinetic studies |
| Jona G. |
- |
Evaluation of a protein microarray assay for detecting antibodies to SARS-coronavirus |
| Jonas D. |
- |
Correlation of antimicrobial use and MRSA rates: data from the project Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units (SARI) |
| |
- |
Antibiotic use and bacterial resistance in German intensive care units: data from project SARI (Surveillance of Antibiotic Use and Bacterial Resistance in German Intensive Care Units) from 2000 to 2004 |
| |
- |
Sporadic and outbreak cases of plasmid-mediated quinolone-resistance in German ICUs |
| |
- |
Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from project SARI (Surveillance of antimicrobial use and antimicrobial resistance in German ICUs) |
| |
- |
SARI: distribution of extended-spectrum beta-lactamases in German ICUs |
| Jonassen T.Ø. |
- |
The unexpected findings of pertussis by 16S rDNA sequencing in broncho-alveolar lavage fluid in an immunocompromised patient in an endemic setting |
| Jonassen T. |
- |
Isolation of Bordetellapertussis in blood culture from a patient with multiple myeloma |
| Jonassen T.O. |
- |
Laboratory diagnostics of Brucella infection risk of laboratory infection |
| Jones R.N. |
- |
Diverse transposons are responsible for the dissemination of Japanese metallo-beta-lactamase alleles: Report from the SENTRY Surveillance Programme |
| Jones R. |
- |
Tigecycline activity tested against 22,950 bloodstream infection isolates worldwide |
| |
- |
Activity of tigecycline tested against an international collection (19992003) of resistant bacterial pathogens |
| |
- |
In vitro evaluation of the peptide deformylase inhibitor LBM415 in combination with aztreonam to determine the synergistic potential against Gram-positive and Gram-negative pathogens |
| |
- |
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY Antimicrobial Surveillance Programme (19992003) |
| Jones M.E. |
- |
Activity of ceftobiprole against recent clinical isolates of Enterobacteriaceae from respiratory infections from hospitalised patients in Europe and USA |
| Jones R. |
- |
Delayed resistance selection for doripenem when passaging P. aeruginosa isolates with an aminoglycoside |
| |
- |
Contemporary activity of gemifloxacin and other fluoroquinolones tested against Streptococcus pneumoniae isolated during 19992004 in Europe and America |
| |
- |
Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcusbovis |
| |
- |
Bactericidal activity of vancomycin and daptomycin tested against heterogeneous and homogeneous vancomycin-intermediate S. aureus (hVISA and VISA) strains |
| |
- |
Linezolid susceptibility testing results in Europe: report from the Worldwide ZAAPS Program (2003) |
| |
- |
Significant increases in the rate of fluoroquinolone resistance among Gram-negative bacilli: six-year (19992004) report from the USA MYSTIC Programme |
| |
- |
In vitro activity of garenoxacin, a novel Des-F(6)-quinolone, and other orally administered antimicrobials tested against 50,217 Enterobacteriaceae collected wordwide by the SENTRY Antimicrobial Surveillance Programme (19992003) |
| |
- |
Potency of garenoxacin, a new des- F(6)-quinolone, tested against community-acquired respiratory tract infection pathogens worldwide (29,837 Strains): report from the SENTRY Antimicrobial Surveillance Programme (19992003) |
| |
- |
Susceptibility patterns for amoxicillin/clavulanate tests mimicking newly indicated formulations and pharmacokinetic relationships: does the 2:1 ratio MIC accurately reflect activity against beta-lactamase-producing H. influenzae and M. catarrhalis |
| Jones M.E. |
- |
In vitro activity of ceftobiprole against recent clinical isolates of Pseudomonas aeruginosa from hospitalised patients in Europe and USA |
| Jones M. |
- |
A baseline assessment of telavancin's activity against a collection of Gram-positive isolates, including resistant phenotypes |
| Jones R. |
- |
Antimicrobial activity of daptomycin tested against Gram-positive strains collected from European medical centres in 2004 |
| Jones M.E. |
- |
Activity and pharmacodynamics of RO4908463 (CS-023), a carbapenem with activity against MRSA |
| Jones R. |
- |
Global evaluation of gemifloxacin activity tested against community-acquired respiratory tract pathogens, Haemophilus influenzae and Moraxella catarrhalis (19992004) |
| Jones M. |
- |
Multidrug resistance among Streptococcus pneumoniae from Europe, Asia and South America: current data from the GLOBAL Surveillance initiative 19992004 |
| Jones R. |
- |
In vitro activity of beta-lactam antimicrobial agent combinations with aztreonam when testing metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter spp. |
| Jones R.N |
- |
Transfer and carriage of naturally occurring Pseudomonas aeruginosa plasmids harbouring metallo-beta-lactamase to Enterobacteriaceae strains |
| Jones R. |
- |
Antimicrobial activity of tigecycline tested against bacterial pathogens from intensive care units |
| |
- |
Potency and spectrum of tigecycline tested against an international collection (19992003) of bacterial pathogens producing skin and soft tissue infections |
| |
- |
Antimicrobial activity and spectrum of cefepime tested against 65,746 clinical strains from North American medical centres: report from the SENTRY Antimicrobial Surveillance Program, 19982004 |
| Jones M. |
- |
The prevalence of multidrug resistance among Streptococcus pneumoniae in the United States |
| Jones M.E. |
- |
Investigation of divergent piperacillin and piperacillin/tazobactam activities to support appropriate formulary decisions |
| Jones R. |
- |
Comparative activity of oral and parenteral cephalosporins against multi-drug-resistant Streptococcus pneumoniae: report from the SENTRY Antimicrobial Surveillance Program (19972003) |
| |
- |
In vitro efficacy of tigecycline tested against community-acquired respiratory tract infection and nosocomial pneumonia pathogens |
| |
- |
Changing antimicrobial susceptibility patterns among S. pneumoniae and H. influenzae from Brazil: report from the SENTRY Antimicrobial Surveillance Programme 19982003 |
| |
- |
In vitro activity of new compounds tested against multi-drug resistant S. aureus isolated in Latin American medical centres |
| |
- |
Accuracy of three automated systems for susceptibility testing selected Gram-negative bacilli against five broad-spectrum beta-lactam agents |
| |
- |
Antimicrobial activity of LBM415 (NVP PDF-713) against a recent (2003) international collection of Gram-positive and respiratory tract pathogens |
| |
- |
Garenoxacin activity against isolates from patients hospitalised with community-acquired pneumonia (Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis; 3,087 strains): report from the SENTRY Antimicrobial Surveillance Programme (1999) |
| |
- |
Antimicrobial susceptibility of 5,859 non-Enterobacteriaceae Gram-negative organisms other than Pseudomonas aeruginosa tested against the novel Des-F(6)-quinolone, garenoxacin (SENTRY Antimicrobial Surveillance Programme, 19992003) |
| Jones R.N. |
- |
Comparison of in vitro activity of cefepime alone or in combination with sulbactam against clinical strains of multi-drug resistant Acinetobacter spp. |
| Jong A. |
- |
Structural characterisation and susceptibility testing of epilancin 15X, a novel antibiotic |
| |
- |
Trends in antimicrobial susceptibility and serotype distribution of nontyphoidalSalmonella from chickens in four European countries during 19982004 |
| Jonsson A-M. |
- |
Quantitation of CMV, EBV and HBV using new sensitive real-time PCR assays |
| Jordan W. |
- |
Effectiveness and durability of tenofovir and didanosine as backbones in anti-retroviral naive patients |
| Jorens P. |
- |
Successful use of posaconazole in a paediatric case of necrotising fasciitis caused by Rhizopus |
| Jorgensen D. |
- |
Single-dose azithromycin microspheres versus 7 days of levofloxacin for the treatment of mild to moderate community-acquired pneumonia in adults |
| Jorgensen B. |
- |
Application of 16S rRNA PCR and DGGE to demonstrate differences in local bacterial colonisation within a single chronic venous leg ulcer |
| Jorgensen D. |
- |
Single-dose azithromycin microspheres versus three-day azithromycin for the treatment of group A beta-haemolytic streptococcal (GABHS) pharyngitis/tonsillitis in adults and adolescents |
| Josling P.D. |
- |
Treatment of chronic MRSA infections using a novel aqueous extract of allicin (AB1000) |
| Jouahia W. |
- |
Antibiotic resistance of Staphylococcus aureus: a Tunisian multicentre study 19992003 |
| Joukhadar C. |
- |
Pharmacokinetics of linezolid in bone tissue investigated by in situ microdialysis |
| Jovanovic S. |
- |
Prevalence of extend-spectrum beta-lactamase producing enterobacteria in different samples of patients hospitalised in a Serbian clinical centre |
| Jovanovic B |
- |
Prevalence of extend-spectrum beta-lactamase producing enterobacteria in different samples of patients hospitalised in a Serbian clinical centre |
| Jover F. |
- |
Impact of an antibiotic restriction policy on antibiotic usage and cost |
| Jozwiak L. |
- |
Evaluation of Staphylococcus aureus nasal carriage rate among patients on haemodialysis - isolation of community-acquired methicillin-resistant Staphylococcus aureus |
| Jørgensen B. |
- |
Stability of the bacterial flora composition in chronic wounds |
| Juan-Bañón J.L. |
- |
Levofloxacin activity on respiratory isolates of Streptococcus pneumoniae with decreased susceptibility to ciprofloxacin in Spain |
| Juda M. |
- |
Dynamics of nasopharyngeal colonisation by coagulase-negative staphylococci in patients with resectable lung cancer during short-term hospitalisation |
| Juncosa T. |
- |
Antibiotic susceptibility, mechanisms of macrolide resistance and clonal relationship in group B streptococci |
| Jung H.-S. |
- |
Hepatitis B virus DNA testing by nested-PCR, PCR-ELISA and hybrid capture II from a blood and blood products |
| Jung S.I. |
- |
Biofilm production and the genotypes of Candida parapsilosis recovered from bloodstream and non-bloodstream sources |
| |
- |
Changes in azole susceptibility and electrophoretic karyotype in sequential bloodstream isolates from patients with Candida glabrata candidaemia |
| Jurczak A. |
- |
Genotypic analysis and occurrence of extended spectrum beta-lactamases (ESBL+) producing Klebsiella spp. strains in a neonatology unit 1 year study |
| Jursa J. |
- |
Genotypic analysis and occurrence of extended spectrum beta-lactamases (ESBL+) producing Klebsiella spp. strains in a neonatology unit 1 year study |
| Jury F. |
- |
Rapid, reliable sub-typing of methicillin-resistant Staphylococcus aureus by denaturing high pressure liquid chromatography and DNA sequence analysis |
| Justesen T. |
- |
Ribosomal DNA sequencing: experiences from use in the Danish national reference laboratory for identification of bacteria |
| Juvin M.E. |
- |
There is no correlation between the minimal inhibitory concentration of teicoplanin against Staphylococcus epidermidis and efficacy in the mouse sepsis/peritonitis model |
| Józwiak J. |
- |
Drug-resistance and drug-sensitiveness of bacterias causing urinary tract infections in women under general practice care in Silesian Province |